Science & Co review
Explains its own asterisk in its own FAQ, and states outright that it is not a compounding facility — while publishing only two figures and no middle rungs.
Pricing last checked on Science & Co's own site .
- Semaglutide
- $149/mo (compounded; $79 only on a 12-month plan)
- Tirzepatide
- $199/mo (compounded; $125 only on a 12-month plan)
- Coverage
- Not publicly listed
- Brand-name
- Compounded only
The scorecard
Science & Co scored on our six published factors. See the methodology.
What we like
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility" — a question most programs never raise
- Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
- The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" on the page
- "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
The caveats
- The number it leads with is a twelve-month commitment — the per-month rates are $149 and $199, roughly 60% higher
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
- It says it is not a compounding facility but does not name the pharmacy that is
- No brand-name option and no oral route published on the pages we read
The verdict
Best for: A twelve-month committer, or anyone who values a company saying plainly what it is and is not. Explains its own asterisk in its own FAQ, and states outright that it is not a compounding facility — while publishing only two figures and no middle rungs.
Ranked #41 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. In the ranking it sits between Idgie Health at #40, 80/100 above and Elara Health and Wellness at #42, 80/100 below, with the StackMD ruling the next one down.
A grade B− is a ranking, not an instruction to stop looking: the closest rivals to Science & Co are ruled on the identical rubric, so the comparison is like for like.For the wider picture, every ruling we have published ranks the field on the same six factors. We have also ruled on it directly: CoreAge Rx vs Science & Co goes to CoreAge Rx, 94/100 to 80/100.
Compare with other providers
The closest rulings to Science & Co by Verdict Score — the realistic shortlist if you are weighing this one up.
- #33Live Vital— Cheap semaglutide and nationwide coverage, with a tirzepatide markup and no LegitScript listing.83/100
- #34REMEVi— REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.83/100
- #35Rx.com— Prints "No automatic renewals" on the plan card and names the pharmacy that dispenses — then advertises a price belonging to a different drug on a different term.82/100
- #36Synergy Rx— Will prescribe brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock access to its clinical team.79/100
- #37Mochi Health— A recognizable coaching-forward brand undercut by a limited state footprint and no LegitScript listing.81/100
- #38Fella Health— A men's-health-focused program with a steep tirzepatide price, a partial state map and no LegitScript listing.81/100
Pricing, states and verification reflect Science & Co's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Science & Co's site. Not medical advice; see our disclosure.